Results about: androgen receptor
Xavier Salvatella, ICREA researcher at IRB Barcelona, proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently available.
The incidence of prostate cancer is increasing worldwide. In the US and Europe, it is one of the most common tumours and among the main causes of death by cancer.
The finding paves the way for the identification of new therapeutic targets for many diseases.
The students enrolled in the second edition of A Future in Biomedicine have just completed their academic year at IRB Barcelona. On 7 June, the five scientists presented the research projects they carried out at IRB Barcelona during their 8-month internships. While pipetting in the lab, they continued to study for their last year of degree at their respective universities. Enric Ros, who worked in Xavier Salvatella's lab, and Anna Ferrer, who joined Angel Nebreda's lab, talk to in vivo about their journey.
Kennedy’s disease leads to progressive muscle wastage. It is a condition that affects only men and it appears between 40 and 50 years of age. There is no specific treatment available.
In individuals with this disease, muscle cells and motor neurons die over the years because they accumulate a protein that is mutated.
Researchers at IRB Barcelona discover that this protein has a self-protective mechanism through which the deleterious effects of the mutation are delayed.